Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

William James

View through CrossRef
In this insightful new book on the remarkable William James, the American psychologist and philosopher, Krister Dylan Knapp provides the first deeply historical and acutely analytical account of James's psychical research. While showing that James always maintained a critical stance toward claims of paranormal phenomena like spiritualism, Knapp uses new sources to argue that psychical research held a strikingly central position in James's life. It was crucial to his familial and professional relationships, the fashioning of his unique intellectual disposition, and the shaping of his core doctrines, especially the will-to-believe, empiricism, fideism, and theories of the subliminal consciousness and immortality. Knapp explains how and why James found in psychical research a way to rethink the well-trodden approaches to classic Euro-American religious thought, typified by the oppositional categories of natural vs. supernatural and normal vs. paranormal. He demonstrates how James eschewed these choices and instead developed a tertiary synthesis of them, an approach Knapp terms tertium quid, the third way. Situating James's psychical research in relation to the rise of experimental psychology and Protestantism's changing place in fin de siècle America, Knapp asserts that the third way illustrated a much broader trend in transatlantic thought as it struggled to navigate the uncertainties and religious adventurism of the modern age.
University of North Carolina Press
Title: William James
Description:
In this insightful new book on the remarkable William James, the American psychologist and philosopher, Krister Dylan Knapp provides the first deeply historical and acutely analytical account of James's psychical research.
While showing that James always maintained a critical stance toward claims of paranormal phenomena like spiritualism, Knapp uses new sources to argue that psychical research held a strikingly central position in James's life.
It was crucial to his familial and professional relationships, the fashioning of his unique intellectual disposition, and the shaping of his core doctrines, especially the will-to-believe, empiricism, fideism, and theories of the subliminal consciousness and immortality.
Knapp explains how and why James found in psychical research a way to rethink the well-trodden approaches to classic Euro-American religious thought, typified by the oppositional categories of natural vs.
supernatural and normal vs.
paranormal.
He demonstrates how James eschewed these choices and instead developed a tertiary synthesis of them, an approach Knapp terms tertium quid, the third way.
Situating James's psychical research in relation to the rise of experimental psychology and Protestantism's changing place in fin de siècle America, Knapp asserts that the third way illustrated a much broader trend in transatlantic thought as it struggled to navigate the uncertainties and religious adventurism of the modern age.

Related Results

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...

Back to Top